SL

SB Life Science

North America, California, United States, Redwood City

Description

SB Life Science Equity Management is a venture capital firm that is dedicated to funding and building successful businesses in health care.

Investor Profile

SB Life Science has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series D (38%)
  • Series C (25%)
  • Post Ipo Equity (13%)
  • Series A (13%)
  • Series B (13%)

Country Focus

  • United States (88%)
  • Canada (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Genetics
  • Therapeutics
  • Medical
  • Hospital
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SB Life Science frequently co-invest with?

BP
North America, California, United States, San Diego
Co-Investments: 3
CSK Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Mizuho Securities
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
CC
North America, California, United States, San Francisco
Co-Investments: 2
BS
Europe, Ticino, Switzerland, Lugano
Co-Investments: 2
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
CS
North America, Georgia, United States, Mcdonough
Co-Investments: 2
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Glynn Capital Management
North America, California, United States, Menlo Park
Co-Investments: 2
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does SB Life Science often collaborate with?

AZ
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by SB Life Science?

EQRx

Cambridge, Massachusetts, United States

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityDec 17, 2021
Amount Raised: $1,200,000,000
Gemin X Pharmaceuticals

Montréal, Quebec, Canada

Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.

BiotechnologyPharmaceuticalTherapeutics
Series CJul 3, 2008
Amount Raised: $38,000,000
CircuLite

Framingham, Massachusetts, United States

CircuLite is a cardiovascular device company, focused on developing minimally-invasive micro-pumps to treat chronic heart failures.

Health CareHospitalMedical Device
Series BApr 23, 2007
Amount Raised: $5,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DJan 6, 2006
Amount Raised: $50,000,000
Optimer Pharmaceuticals

San Diego, California, United States

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DDec 14, 2005
Amount Raised: $22,200,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DFeb 28, 2005
Amount Raised: $74,000,000
Kadmus Pharmaceuticals

San Mateo, California, United States

Kadmus Pharmaceuticals, Inc., a biopharmaceutical company, commercially exploits endocannabinoid pathways to develop therapeutics.

BiotechnologyHealth CarePharmaceutical
Series AFeb 10, 2004
Amount Raised: $15,300,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CJan 28, 2003
Amount Raised: $30,000,000